產(chǎn)品供應(yīng)順式-(1R,3R)-1,2,3,4-四氫-1-(3,4-亞甲二氧基苯基)-9H-吡啶并[3,4-B]吲哚-3-羧酸甲酯鹽酸鹽

  • 發(fā)布日期：2024-12-17
  • 有效期限：30天
濟(jì)南共創(chuàng)醫(yī)藥科技有限公司 VIP
C20H19ClN2O4
386.8289
回上一頁(yè) 在線詢盤 打印本頁(yè)
詳細(xì)信息
  • ;四氫咔啉鹽酸鹽(異構(gòu)體雜質(zhì));他達(dá)那非N-2中間體;（順式-1-（1,3-苯并二氧雜環(huán)戊烯-5-基）-2,3,4,9，-四氫-1氫-吡啶并[3,4-b]吲哚-3-羧酸甲酯鹽酸鹽）;
  • (1R,3R)-9H-pyrido[3,4-B]indole-3-carboxylic acid, 1,2,3,4-tetrahydro-1-(3,4-methylenedioxyphenyl), methyl ester, hydrochloride
  • ;chempacific 51475;Intermediates of tadalafil:(1R,3R)-9H-pyrido[3,4-B]indole-3-carboxylic acid, 1,2,3,4-tetrahydro-1-(3,4-methylenedioxyphenyl), methyl ester, Cis Isomer, hydrochloride;[171596-44-4], C20H18N2O4,350.13;1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-;1H-Pyrido[3,4-b]indole-3-carboxylicacid;methylester, monohydrochloride, (1R,3R)-;methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-β-carboline-3-carboxylate hydrochloride (1:1);(1R,3R)-methyl 1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate hydrochloride;(1R,3R)-9H-Pyrido[3,4-B]Indole-3-Carboxylic Acid, 1,2,3,4-Tetrahydro-1-(3,4-Methylenedioxyph Enyl), Methyl Ester, Hydrochloride;cis-(1R,3R)-1,2,3,4-Tetrahydro-1-(3,4-methylenedioxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxylic acid methyl ester hydrochloride;
  • InChI=1/C20H18N2O4.ClH/c1-24-20(23)15-9-13-12-4-2-3-5-14(12)21-19(13)18(22-15)11-6-7-16-17(8-11)26-10-25-16;/h2-8,15,18,21-22H,9-10H2,1H3;1H/t15-,18-;/m1./s1
  • 552.2°C at 760 mmHg
  • 287.8°C

  • 他達(dá)拉非N-2中間體
    （順式-(1R,3R)-1,2,3,4-四氫-1-(3,4-亞甲二氧基苯基)-9H-吡啶并[3,4-B]吲哚-3-羧酸甲酯鹽酸鹽）
    a) 英文名：
    (1R,3R)-9H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLIC ACID, 1,2,3,4-TETRAHYDRO-1-(3,4-METHYLENEDIOXYPH ENYL)
    b) CAS登記號(hào)：171752-68-4
    c) 分子式：C12H8N2O2
    d) 含量：≥99%
    e) 用途：用于合成他達(dá)拉非原料 本品用于實(shí)驗(yàn)室研究

  • CAS NO：171752-68-4

免責(zé)聲明：以上所展示的信息由企業(yè)自行提供，內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布企業(yè)負(fù)責(zé)，化工網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。我們?cè)瓌t上建議您選擇化工網(wǎng)高級(jí)會(huì)員或VIP會(huì)員。